2.71
-0.04(-1.45%)
Currency In USD
| Previous Close | 2.75 |
| Open | 2.88 |
| Day High | 2.8 |
| Day Low | 2.66 |
| 52-Week High | 8.94 |
| 52-Week Low | 1.8 |
| Volume | 247,592 |
| Average Volume | 183,514 |
| Market Cap | 42.91M |
| PE | -2.04 |
| EPS | -1.33 |
| Moving Average 50 Days | 4.35 |
| Moving Average 200 Days | 3.43 |
| Change | -0.04 |
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
Newsfile
Jun 02, 2025 5:40 PM GMT
Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.1
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering
Newsfile
May 30, 2025 12:30 AM GMT
Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit
Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Newsfile
May 22, 2025 11:30 AM GMT
The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAEPhiladelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "